Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inovio
Biotech
Inovio trims team as trouble brews at FDA for rare disease drug
The layoffs come as the FDA warns that it might not consider Inovio's rare disease candidate for accelerated approval after all.
Darren Incorvaia
Mar 13, 2026 10:03am
Inovio drafts accelerated approval talking points for FDA visit
Nov 10, 2023 7:28am
2023 biopharma layoffs now match 2022's total
Aug 21, 2023 11:37am
Inovio says no-go on phase 3 program, lays off 30% of staff
Aug 10, 2023 8:00am
Inovio's endpoint switcheroo backfires as phase 3 fails new test
Mar 2, 2023 5:20am
Inovio hopes Ebola booster data can boost fortunes, too
Feb 2, 2023 9:50am